Imagin tablets are indicated for the treatment of type 2 diabetes mellitus. Clinical studies have shown the promising efficacy of Imagin both as a monotherapy and in combination therapies, with an acceptable safety profile.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Imagin (Imeglimin) works through dual mechanisms:
At a cellular level, Imeglimin targets mitochondrial dysfunction, a common factor in the development of Type 2 Diabetes (T2D). It helps correct mitochondrial activity, reduces oxidative stress by lowering reactive oxygen species (ROS), and prevents mitochondrial cell death. Imeglimin enhances glucose-stimulated ATP production and increases NAD+ synthesis, further improving insulin action and glucose handling. It has been shown to preserve β-cell mass in rodents with T2D.
This unique mechanism distinguishes Imagin from other diabetes medications like biguanides, sulfonylureas, and GLP-1 receptor agonists.
Type 2 diabetes mellitus
Amplification of Glucose-Stimulated Insulin Secretion (GSIS) and preservation of β-cell mass: Imeglimin enhances the pancreas’s ability to secrete insulin in response to glucose and helps preserve the β-cells, which are critical for insulin production.
Enhanced Insulin Action: It improves the body’s insulin sensitivity, particularly in the liver and skeletal muscles. Imeglimin may also inhibit the liver's glucose output, helping to regulate blood sugar levels more effectively.
On a cellular and molecular level, Imeglimin corrects mitochondrial dysfunction, which is a key factor in the development of Type 2 Diabetes (T2D). Mitochondria play an essential role in energy production and cell function, and dysfunction in these structures can impair insulin action. Imeglimin works by:
By addressing mitochondrial dysfunction, Imeglimin restores proper cellular energy metabolism, a core defect in T2D. This action is unique compared to other diabetes medications like biguanides (e.g., metformin), sulfonylureas, and GLP-1 receptor agonists, which work through different mechanisms.
In essence, Imeglimin targets the root cause of T2D—defective energy metabolism—offering a novel approach to managing the disease.
For adults:
Store below 30°C in a dry place, away from light. Keep all medications out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.